Elidah Welcomes the New Year with New Funding for Incontinence Therapy

Share Article

New discreet medical device opens door to conservative therapy options for those suffering from urinary incontinence.

Women and men are a step closer to an at-home treatment that is non-invasive.

Elidah (http://www.elidah.com) has received multiple awards for further development of its neuromuscular stimulation technology to treat incontinence. Elidah has received a grant from the National Science Foundation (NSF) to continue development of its wearable device, Elitone, designed to treat urinary incontinence, a condition that affects one in three women. Additionally, the Defense Health Agency (DHA) Small Business Innovation Research (SBIR) Program in the Department of Defense (DoD) has awarded Elidah a contract to develop and adapt the Elitone technology for the treatment of injured Service members. These awards start in January 2018.

Elitone is a discreet, non-invasive device designed to restore urinary continence, not just manage incontinence symptoms. The muscular atrophy of a weakened pelvic floor results in stress incontinence, while urge incontinence is caused by nerves overstimulating the bladder often as the body ages. The device works by electrically stimulating the perineal tissue, causing the pelvic floor muscles to contract and strengthen over time. Elitone is designed for use in the comfort of one’s own home and can be worn underneath clothing while going about daily activity. Elidah seeks to provide women with a conservative, accessible way to treat incontinence. The company expects to receive regulatory clearance and begin marketing the product later this year.

The NSF grant, part of the Technology Enhancement for Commercial Partnerships (TECP) program, is intended to support product refinement in advance of a potential business relationship with an established corporate partner, one of US’s largest medical device manufacturers. This grant supplements a previous SBIR award, and Elidah intends to use this grant to evaluate biofeedback capabilities to improve treatment efficacy.

The DoD contract funds development of new technologies that restore urinary function and control to injured service members, including those with spinal cord injury. Building on the existing Elitone technology, Elidah will develop a diagnostic and therapeutic device to treat these injured military personnel. Broader application of this technology may treat civilian men who suffer from urinary incontinence, often a side effect of prostate surgery. This work is supported by the Combat Casualty Care Research Program and the US Army Medical Research and Materiel Command under Contract No. W81XWH-18-C-0063.

About Elidah
Elidah is a women-owned medical device company established in 2014 to help women around the world who suffer from incontinence. Elidah is developing technologies that integrate recent advances in wearable devices, biomaterials and mobile interfaces to deliver innovative therapeutic solutions that are non-invasive, comfortable and convenient. Elidah is led by entrepreneur Gloria Kolb, Founder and CEO, an MIT and Stanford trained engineer whose previous accolades include Boston’s 40 under 40 and MIT Technology Review’s World Top Innovators Under 35 (TR35). To learn more visit http://www.elidah.com and http://www.elitone.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Gloria Kolb
+1 978-435-4324
Email >
since: 04/2015
Follow >
Visit website